Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

WINTHROP-BREON DISTRIBUTING 42,000 POSTERS, "TALK ABOUT PRESCRIPTIONS,"

Executive Summary

WINTHROP-BREON DISTRIBUTING 42,000 POSTERS, "TALK ABOUT PRESCRIPTIONS," to MDs as part of the National Council on Patient Information & Education's (NCPIE) public education campaign on medication awareness. The posters and other campaign materials urge patients and health care professionals to discuss five basic topics: (1) the name and purpose of the drug treatment; (2) dosing regimen; (3) taking the medication with foods, drinks and other medications; (4) side effects; and (5) sources of written information about the drug. NCPIE is pushing the "Talk About Prescriptions" campaign throughout the month of October. The council kicked off the event with a press conference in Washington on Oct. 2. NCPIE Chairman Paul Rogers told the press conference that the objectives of the campaign are "to stimulate nationwide awareness of the need for improved communication about prescription medicines; and to promote individual, organizational and community action that motivates health professionals to give -- and consumers to seek -- the information needed for safe and effective drug use." HHS Asst. Secty. Robert Windom described the problem of misuse or underused drugs as large scale. He maintained: "Half of all prescribed medicines are taken incorrectly. That would be about 800 mil. prescriptions out of 1.6 bil. that are written a year in this country." Adverse effects from misuse are in two main categories -- one such as in death from the overdose of aspirin and the other complications or death from overdose or underdose of cardiovascular drugs, those used for arrythmia and hypertension. NCPIE is sending posters, brochures, planning kits, wallet cards and buttons, which provide steps to improving information on medicines, to health associations, hospitals and consumers. At the kick-off press conference, NCPIE Chairman Rogers noted that the posters urging patient-doctor communication are also being sent by the American Hospital Association to 4,000 hospitals. USP is providing buttons to the nation's 57,000 pharmacies. Citicorp is enclosing program material in a special message to 900,000 Choice credit card holders.

You may also be interested in...



Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance

FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials

Shire Hopes To Sow Future Deals With $50M Venture Fund

Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth

UsernamePublicRestriction

Register

LL1133990

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel